Protective Role of Natural IgM-Producing B1a Cells in Atherosclerosis

Trends in Cardiovascular Medicine

Volumn 22, Issue 2, 2012, Pages 48-53

  Kyaw, Tin ^a,b   Tipping, Peter ^b,c   Bobik, Alex ^a   Toh, Ban Hock ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD9 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTEGRIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B1A LYMPHOCYTE; CELL EXPANSION; CYTOKINE PRODUCTION; HUMAN; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SPLEEN; T LYMPHOCYTE;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; B-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN M; INTERLEUKIN-10; LIPOPROTEINS, LDL;

EID: 84865973927     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.06.011     Document Type: Review

References (72)

1. Ait-Oufella H., Herbin O., Bouaziz J.D., et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010, 207:1579-1587.
2. Almeida S.R., Aroeira L.S., Frymuller E., et al. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int Immunol 2001, 13:1193-1201.
3. Ansel K.M., Harris R.B., Cyster J.G. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity 2002, 16:67-76.
4. Aramaki M., Nagasawa T., Koseki T., Ishikawa I. Presence of activated B-1 cells in chronic inflamed gingival tissue. J Clin Immunol 1998, 18:421-429.
5. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Semin Immunopathol 2005, 26:347-362.
6. Berland R., Wortis H.H. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002, 20:253-300.
7. Binder C.J. Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 2010, 30(Suppl 1):S56-S60.
8. Binder C.J., Hörkkö S., Dewan A., et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003, 9:736-743.
9. Binder C.J., Shaw P.X., Chang M.K., et al. The role of natural antibodies in atherogenesis. J Lipid Res 2005, 46:1353-1363.
10. Caligiuri G., Nicoletti A., Poirier B., Hansson G.K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002, 109:745-753.
11. Caligiuri G., Rudling M., Ollivier V., et al. Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol Med 2003, 9:10-17.
12. Chang M.K., Binder C.J., Miller Y.I., et al. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med 2004, 200:1359-1370.
13. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995, 7:812-818.
14. Doran A.C., Lipinski M.J., Oldham S.N., et al. B-cell aortic homing and atheroprotection depend on Id3. Circ Res 2012, 110:e1-e12.
15. Driessler F., Venstrom K., Sabat R., et al. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: A role for p50. Clin Exp Immunol 2004, 135:64-73.
16. Duan B., Morel L. Role of B-1a cells in autoimmunity. Autoimmun Rev 2006, 5:403-408.
17. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007, 178:7868-7878.
18. Faria-Neto J.R., Chyu K.Y., Li X., et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis 2006, 189:83-90.
19. Fillatreau S., Sweenie C.H., McGeachy M.J., et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
20. Fiorentino D.F., Zlotnik A., Vieira P., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991, 146:3444-3451.
21. Ghosn E.E., Yang Y., Tung J., Herzenberg L.A. CD11b expression distinguishes sequential stages of peritoneal B-1 development. Proc Natl Acad Sci U S A 2008, 105:5195-5200.
22. Gorelik L., Cutler A.H., Thill G., et al. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 2004, 172:762-766.
23. -. J Exp Med 2011, 208:67-80.
24. Griffin D.O., Rothstein T.L. A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus. J Exp Med 2011, 208:2591-2598.
25. Ha S.A., Tsuji M., Suzuki K., et al. Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med 2006, 203:2541-2550.
26. Haas K.M., Poe J.C., Steeber D.A., Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to Spneumoniae. Immunity 2005, 23:7-18.
27. Harris D.P., Haynes L., Sayles P.C., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482.
28. Hartvigsen K., Chou M.Y., Hansen L.F., et al. The role of innate immunity in atherogenesis. J Lipid Res 2009, 50(Suppl):S388-S393.
29. - peritoneal B cells: A novel B cell subset that exhibits characteristics of B-1 cells. Immunol Lett 2006, 105:90-96.
30. Hayakawa K., Carmack C.E., Hyman R., Hardy R.R. Natural autoantibodies to thymocytes: Origin, VH genes, fine specificities, and the role of Thy-1 glycoprotein. J Exp Med 1990, 172:869-878.
31. Hayakawa K., Hardy R.R., Honda M., et al. Ly-1 B cells: Functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A 1984, 81:2494-2498.
32. Heeschen C., Dimmeler S., Hamm C.W., et al. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 2003, 107:2109-2114.
33. Hoffmann A., Kerr S., Jellusova J., et al. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol 2007, 8:695-704.
34. + B1 cells containing abundant N-region additions. Eur J Immunol 2009, 39:2383-2394.
35. Jellusova J., Düber S., Gückel E., et al. Siglec-G regulates B1 cell survival and selection. J Immunol 2010, 185:3277-3284.
36. Kantor A.B., Herzenberg L.A. Origin of murine B cell lineages. Annu Rev Immunol 1993, 11:501-538.
37. Kawahara T., Ohdan H., Zhao G., et al. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol 2003, 171:5406-5414.
38. Koppelman B., Neefjes J.J., de Vries J.E., de Waal Malefyt R. Interleukin-10 downregulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 1997, 7:861-871.
39. Kyaw T., Tay C., Hosseini H., et al. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS ONE 2012, 7:e29371.
40. Kyaw T., Tay C., Khan A., et al. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010, 185:4410-4419.
41. Kyaw T., Tay C., Krishnamurthi S., et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011, 109:830-840.
42. Lampropoulou V., Hoehlig K., Roch T., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008, 180:4763-4773.
43. Lewis M.J., Malik T.H., Ehrenstein M.R., et al. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 2009, 120:417-426.
44. Mackay F., Browning J.L. BAFF: A fundamental survival factor for B cells. Nat Rev Immunol 2002, 2:465-475.
45. Major A.S., Fazio S., Linton M.F. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002, 22:1892-1898.
46. + B lymphocytes. Int Immunol 1990, 2:515-520.
47. Mauri C., Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012, 30:221-241.
48. Mauri C., Ehrenstein M.R. The "short" history of regulatory B cells. Trends Immunol 2008, 29:34-40.
49. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501.
50. + murine B cell lymphomas specific for erythrocyte membranes. J Exp Med 1986, 163:155-165.
51. + (CD5) B cells that recognize phosphatidyl choline: Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J Exp Med 1988, 168:687-698.
52. Montecino-Rodriguez E., Dorshkind K. B-1 B cell development in the fetus and adult. Immunity 2012, 36:13-21.
53. Murakami M., Tsubata T., Shinkura R., et al. Oral administration of lipopolysaccharides activates B-1 cells in the peritoneal cavity and lamina propria of the gut and induces autoimmune symptoms in an autoantibody transgenic mouse. J Exp Med 1994, 180:111-121.
54. Noh G., Lee J.H. Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res 2011, 3:168-177.
55. O'Garra A., Chang R., Go N., et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992, 22:711-717.
56. Ogden C.A., Kowalewski R., Peng Y., et al. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 2005, 38:259-264.
57. Palinski W., Hörkkö S., Miller E., et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996, 98:800-814.
58. Rauch P.J., Chudnovskiy A., Robbins C.S., et al. Innate response activator B cells protect against microbial sepsis. Science 2012, 335:597-601.
59. Robbins C.S., Chudnovskiy A., Rauch P.J., et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 2012, 125:364-374.
60. Rothstein T.L., Kolber D.L. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J Immunol 1988, 140:2880-2885.
61. Sabat R., Grütz G., Warszawska K., et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010, 21:331-344.
62. Sage A.P., Tsiantoulas D., Baker L., et al. BAFF receptor deficiency reduces the development of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2012, 32:1573-1576.
63. Shaw P.X., Hörkkö S., Chang M.K., et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000, 105:1731-1740.
64. Stall A.M., Adams S., Herzenberg L.A., Kantor A.B. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann N Y Acad Sci 1992, 651:33-43.
65. Tsimikas S., Brilakis E.S., Lennon R.J., et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 2007, 48:425-433.
66. Vink A., Warnier G., Brombacher F., Renauld J.C. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J Exp Med 1999, 189:1413-1423.
67. -/- mice. FASEB J 2001, 15:2730-2732.
68. Wardemann H., Boehm T., Dear N., Carsetti R. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 2002, 195:771-780.
69. Watanabe N., Nisitani S., Ikuta K., et al. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med 1999, 190:461-469.
70. Wilson E.H., Katz E., Goodridge H.S., et al. In vivo activation of murine peritoneal B1 cells by the filarial nematode phosphorylcholine-containing glycoprotein ES-62. Parasite Immunol 2003, 25:463-466.
71. Won W.J., Kearney J.F. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002, 168:5605-5611.
72. Ylä-Herttuala S., Palinski W., Butler S.W., et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994, 14:32-40.